Detalhe da pesquisa
1.
Single-cell analysis of refractory anti-SRP necrotizing myopathy treated with anti-BCMA CAR-T cell therapy.
Proc Natl Acad Sci U S A
; 121(6): e2315990121, 2024 Feb 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-38289960
2.
B cell lineage reconstitution underlies CAR-T cell therapeutic efficacy in patients with refractory myasthenia gravis.
EMBO Mol Med
; 16(4): 966-987, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38409527
3.
Single-cell analysis of anti-BCMA CAR T cell therapy in patients with central nervous system autoimmunity.
Sci Immunol
; 9(95): eadj9730, 2024 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-38728414
4.
Anti-BCMA CAR T-cell therapy CT103A in relapsed or refractory AQP4-IgG seropositive neuromyelitis optica spectrum disorders: phase 1 trial interim results.
Signal Transduct Target Ther
; 8(1): 5, 2023 01 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-36596762
5.
[Medicated serum prepared with Chinese herbal medicine Zhizhen Recipe down-regulates activity of nuclear factor-κB and expression of P-glycoprotein in human colorectal cancer multidrug-resistant cell line HCT-8/VCR].
Zhong Xi Yi Jie He Xue Bao
; 9(12): 1353-9, 2011 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-22152775